Lantern Pharma: Precision Medicine Pioneers

By |2019-08-05T20:09:02+00:00March 2nd, 2017|

Lantern Pharma: Precision Medicine Pioneers According to a recent study, the overall success rate for drugs moving through clinical trials to approval by the US Food and Drug Administration is only about 10%. Even though cancer is the most closely studied disease for drug development, oncology drugs have the toughest time making their [...]